Meta tags:

Headings (most frequently used words):

filings, section, 16, sec, forward, looking, statement, investors,

Text of the page (most frequently used words):
page (203), and (61), solutions (52), management (28), safety (16), #statement (14), diagnostic (14), form (12), securities (12), center (12), the (11), filings (10), beneficial (10), ownership (10), surgery (10), patient (10), hypodermic (10), needle (10), syringe (10), drug (10), company (9), support (9), statements (9), overview (9), our (8), forward (8), looking (8), changes (8), medication (8), sepsis (8), integrated (8), original (8), equipment (8), manufacturing (8), oem (8), all (7), other (6), events (6), sec (6), asia (6), africa (6), north (6), united (6), about (6), customer (6), surgical (6), ambulatory (6), vascular (6), access (6), vam (6), microbiology (6), hazardous (6), accuracy (6), efficiency (6), clinical (6), are (5), news (5), investors (5), expectations (5), results (5), section (5), reports (5), corporate (5), risks (4), uncertainties (4), from (4), any (4), annual (4), with (4), financial (4), board (4), login (4), south (4), middle (4), east (4), turkey (4), europe (4), america (4), states (4), canada (4), supplier (4), global (4), policies (4), process (4), device (4), distributor (4), pharmaceutical (4), lab (4), cervical (4), cancer (4), screening (4), portfolio (4), antimicrobial (4), resistance (4), targeted (4), temperature (4), accessibility (3), use (3), training (3), ethics (3), compliance (3), media (3), blogs (3), literature (3), for (3), cybersecurity (3), careers (3), email (3), such (3), business (3), information (3), assumptions (3), may (3), growth (3), product (3), development (3), directors (3), sustainability (3), faq (3), leadership (3), skip (3), privacy (2), website (2), contact (2), trademarks (2), becton (2), dickinson (2), 2026 (2), rss (2), rss_feed (2), contacts (2), alerts (2), based (2), current (2), involve (2), actual (2), could (2), materially (2), implied (2), that (2), differ (2), date (2), this (2), time (2), analyst (2), similar (2), words (2), future (2), content (2), 190 (2), filing (2), initial (2), view (2), quarterly (2), accounting (2), governance (2), stock (2), data (2), info (2), southeast (2), 대한민국 (2), india (2), greater (2), australia (2), new (2), zealand (2), pacific (2), kingdom (2), schweiz (2), polska (2), österreich (2), nordics (2), nederland (2), italia (2), ישראל (2), france (2), españa (2), deutschland (2), česká (2), republika (2), belgië (2), belgique (2), colombia (2), chile (2), argentina (2), américa (2), latina (2), mexico (2), recognition (2), programs (2), procurement (2), doing (2), suppliers (2), recent (2), mergers (2), acquisitions (2), quality (2), guidelines (2), idea (2), submission (2), innovation (2), external (2), funding (2), opportunities (2), transparency (2), supply (2), chain (2), impact (2), healthy (2), workforce (2), communities (2), climate (2), change (2), unique (2), identifier (2), udi (2), list (2), distributors (2), helpful (2), resources (2), disclosure (2), bulletins (2), patches (2), trust (2), fluid (2), segments (2), learning (2), care (2), portal (2), guides (2), portals (2), knowledge (2), venous (2), technology (2), plastic (2), reconstructive (2), hernia (2), repair (2), pharmacy (2), laboratory (2), medical (2), manufacturer (2), delivery (2), systems (2), stone (2), clinician (2), administrator (2), products (2), your, choices, terms, notice, cookie, preferences, rights, reserved, logo, property, their, respective, owners, inclusion, engagement, electronic, instructions, recalls, field, actions, quick, links, follow, sitemap, account_tree, feed, contact_page, upon, number, vary, anticipated, described, projected, many, these, beyond, control, discussion, certain, factors, cause, see, latest, report, expressly, disclaims, undertaking, update, revise, set, forth, herein, reflect, circumstances, after, hereof, except, required, applicable, law, regulation, included, provided, through, webcasts, conference, calls, meetings, road, show, presentations, investor, conferences, newsletters, communications, contains, defined, under, federal, laws, ever, materialize, prove, incorrect, those, expressed, identified, plan, expect, believe, intend, will, anticipate, estimate, meaning, conjunction, among, things, discussions, operations, performance, including, volume, pricing, sales, earnings, per, share, cash, flows, regarding, strategy, regulatory, approvals, competitive, position, expenditures, reading, you, acknowledging, 189, 188, 187, 186, 185, 184, 183, 182, 181, 180, 179, 178, 177, 176, 175, 174, 173, 172, 171, 170, 169, 168, 167, 166, 165, 164, 163, 162, 161, 160, 159, 158, 157, 156, 155, 154, 153, 152, 151, 150, 149, 148, 147, 146, 145, 144, 143, 142, 141, 140, 139, 138, 137, 136, 135, 134, 133, 132, 131, 130, 129, 128, 127, 126, 125, 124, 123, 122, 121, 120, 119, 118, 117, 116, 115, 114, 113, 112, 111, 110, 109, 108, 107, 106, 105, 104, 103, 102, 101, 100, select, arrow_forward, next, pages, xbrl, description, 1994, 1995, 1996, 1997, 1998, 1999, 2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025, year, type, reporting, internal, controls, auditing, matters, documents, dividends, split, history, coverage, historical, quote, chart, additional, credit, rating, proxy, executive, notices, innovates, calendar, press, releases, academy, footer, navigation, main, bdx,

Text of the page (random words):
section 16 filings becton dickinson and company bdx skip to main content skip to section navigation skip to footer products solutions administrator ambulatory surgery center solutions bd hypodermic needle and syringe solutions diagnostic accuracy and efficiency hazardous drug safety integrated diagnostic solutions medication management solutions patient safety solutions sepsis management surgical solutions targeted temperature management vascular access management vam clinician ambulatory surgery center solutions antimicrobial resistance bd original equipment manufacturing oem bd hypodermic needle and syringe solutions cervical cancer screening portfolio clinical and lab support diagnostic accuracy and efficiency hazardous drug safety integrated diagnostic solutions medication management solutions patient safety solutions sepsis management stone management surgical solutions targeted temperature management vascular access management vam distributor bd original equipment manufacturing oem bd hypodermic needle and syringe solutions drug development company drug delivery systems medical device manufacturer bd original equipment manufacturing oem laboratory antimicrobial resistance bd original equipment manufacturing oem cervical cancer screening portfolio clinical and lab support clinical microbiology diagnostic accuracy and efficiency integrated diagnostic solutions patient safety solutions pharmaceutical microbiology sepsis management pharmacy bd hypodermic needle and syringe solutions hazardous drug safety integrated diagnostic solutions medication management solutions patient safety solutions pharmaceutical microbiology sepsis management vascular access management vam surgery ambulatory surgery center solutions bd hypodermic needle and syringe solutions hernia repair solutions patient safety solutions plastic and reconstructive surgery solutions surgical solutions venous technology knowledge center events literature training support customer portals medication management customer login customer care portal guides and faq s bd learning academy about bd our company about bd segments leadership board of directors ethics and compliance bd iv fluid support cybersecurity at bd about us trust center bulletins and patches disclosure process helpful resources distributors distributor list unique device identifier udi corporate sustainability climate change healthy workforce communities product impact supply chain transparency global external funding opportunities investors innovation at bd overview bd idea submission process news media and blogs policies guidelines and statements center quality recent mergers and acquisitions suppliers corporate policies and expectations doing business with bd global procurement supplier programs supplier recognition careers united states north america canada en canada fr mexico united states south america américa latina argentina chile colombia europe belgique belgië česká republika deutschland españa europe france ישראל italia nederland nordics österreich polska schweiz united kingdom middle east north africa turkey middle east north africa turkey south africa asia pacific australia new zealand 中国 greater asia india 日本 대한민국 southeast asia login products solutions administrator ambulatory surgery center solutions bd hypodermic needle and syringe solutions diagnostic accuracy and efficiency hazardous drug safety integrated diagnostic solutions medication management solutions patient safety solutions sepsis management surgical solutions targeted temperature management vascular access management vam clinician ambulatory surgery center solutions antimicrobial resistance bd original equipment manufacturing oem bd hypodermic needle and syringe solutions cervical cancer screening portfolio clinical and lab support diagnostic accuracy and efficiency hazardous drug safety integrated diagnostic solutions medication management solutions patient safety solutions sepsis management stone management surgical solutions targeted temperature management vascular access management vam distributor bd original equipment manufacturing oem bd hypodermic needle and syringe solutions drug development company drug delivery systems medical device manufacturer bd original equipment manufacturing oem laboratory antimicrobial resistance bd original equipment manufacturing oem cervical cancer screening portfolio clinical and lab support clinical microbiology diagnostic accuracy and efficiency integrated diagnostic solutions patient safety solutions pharmaceutical microbiology sepsis management pharmacy bd hypodermic needle and syringe solutions hazardous drug safety integrated diagnostic solutions medication management solutions patient safety solutions pharmaceutical microbiology sepsis management vascular access management vam surgery ambulatory surgery center solutions bd hypodermic needle and syringe solutions hernia repair solutions patient safety solutions plastic and reconstructive surgery solutions surgical solutions venous technology knowledge center events literature training support customer portals medication management customer login customer care portal guides and faq s my bd learning about bd our company about bd segments leadership board of directors ethics and compliance bd iv fluid support cybersecurity at bd about us trust center bulletins and patches disclosure process helpful resources distributors distributor list unique device identifier udi corporate sustainability climate change healthy workforce communities product impact supply chain transparency global external funding opportunities investors innovation at bd overview bd idea submission process news media and blogs policies guidelines and statements center quality recent mergers and acquisitions suppliers corporate policies and expectations doing business with bd global procurement supplier programs supplier recognition careers united states north america canada en canada fr mexico united states south america américa latina argentina chile colombia europe belgique belgië česká republika deutschland españa europe france ישראל italia nederland nordics österreich polska schweiz united kingdom middle east north africa turkey middle east north africa turkey south africa asia pacific australia new zealand 中国 greater asia india 日本 대한민국 southeast asia login section 16 filings investors investors overview news events overview press releases ir calendar bd innovates email alerts other notices company info overview executive leadership annual reports and proxy contacts faq financial info overview financial results credit rating additional financial information stock data quote and chart historical data analyst coverage stock split history dividends sec filings overview all sec filings annual reports quarterly reports section 16 filings corporate sustainability governance overview board of directors governance documents contact the board reporting accounting internal accounting controls or auditing matters sec filings overview all sec filings annual reports quarterly reports section 16 filings filing type view all 3 3 a 4 4 a 5 5 a year view all 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 sec filings date form description xbrl pages 06 25 26 4 form 4 statement of changes in beneficial ownership of securities 1 06 22 26 3 form 3 initial statement of beneficial ownership of securities 5 06 11 26 4 form 4 statement of changes in beneficial ownership of securities 1 06 03 26 4 form 4 statement of changes in beneficial ownership of securities 1 06 02 26 4 form 4 statement of changes in beneficial ownership of securities 1 06 02 26 3 form 3 initial statement of beneficial ownership of securities 5 05 27 26 4 form 4 statement of changes in beneficial ownership of securities 1 05 08 26 4 form 4 statement of changes in beneficial ownership of securities 1 05 08 26 4 form 4 statement of changes in beneficial ownership of securities 1 05 08 26 4 form 4 statement of changes in beneficial ownership of securities 1 rss_feed filing rss page 1 page 2 page 3 page 4 page 5 page 6 page 7 page 8 page 9 page 10 page 190 next page arrow_forward select a page page 1 page 2 page 3 page 4 page 5 page 6 page 7 page 8 page 9 page 10 page 11 page 12 page 13 page 14 page 15 page 16 page 17 page 18 page 19 page 20 page 21 page 22 page 23 page 24 page 25 page 26 page 27 page 28 page 29 page 30 page 31 page 32 page 33 page 34 page 35 page 36 page 37 page 38 page 39 page 40 page 41 page 42 page 43 page 44 page 45 page 46 page 47 page 48 page 49 page 50 page 51 page 52 page 53 page 54 page 55 page 56 page 57 page 58 page 59 page 60 page 61 page 62 page 63 page 64 page 65 page 66 page 67 page 68 page 69 page 70 page 71 page 72 page 73 page 74 page 75 page 76 page 77 page 78 page 79 page 80 page 81 page 82 page 83 page 84 page 85 page 86 page 87 page 88 page 89 page 90 page 91 page 92 page 93 page 94 page 95 page 96 page 97 page 98 page 99 page 100 page 101 page 102 page 103 page 104 page 105 page 106 page 107 page 108 page 109 page 110 page 111 page 112 page 113 page 114 page 115 page 116 page 117 page 118 page 119 page 120 page 121 page 122 page 123 page 124 page 125 page 126 page 127 page 128 page 129 page 130 page 131 page 132 page 133 page 134 page 135 page 136 page 137 page 138 page 139 page 140 page 141 page 142 page 143 page 144 page 145 page 146 page 147 page 148 page 149 page 150 page 151 page 152 page 153 page 154 page 155 page 156 page 157 page 158 page 159 page 160 page 161 page 162 page 163 page 164 page 165 page 166 page 167 page 168 page 169 page 170 page 171 page 172 page 173 page 174 page 175 page 176 page 177 page 178 page 179 page 180 page 181 page 182 page 183 page 184 page 185 page 186 page 187 page 188 page 189 page 190 by reading this content you are acknowledging our forward looking statement forward looking statement the information included on this website and other information provided from time to time through webcasts conference calls securities analyst meetings road show presentations investor conferences newsletters and similar events and communications contains forward looking statements as defined under federal securities laws based on current expectations and assumptions that involve risks and uncertainties if the risks or uncertainties ever materialize or the assumptions prove incorrect the results of bd may differ materially from those expressed or implied by such forward looking statements and assumptions forward looking statements may be identified by the use of words such as plan expect believe intend will may anticipate estimate and other words of similar meaning in conjunction with among other things discussions of future operations and financial performance including volume growth pricing sales and earnings per share growth and cash flows and statements regarding our strategy for growth future product development regulatory approvals competitive position and expenditures all such statements are based upon current expectations of bd and involve a number of business risks and uncertainties actual results could vary materially from anticipated results described implied or projected in any forward looking statement many of these risks and uncertainties are beyond the company s control for a discussion of certain factors that could cause our actual results to differ from our expectations in any forward looking statements see our latest annual report on form 10 k and other filings with the sec bd expressly disclaims any undertaking to update or revise any forward looking statements set forth herein to reflect events or circumstances after the date hereof except as required by applicable law or regulation email email alerts contact_page contacts rss_feed rss news feed account_tree sitemap accessibility accessibility statement follow us quick links recalls and field actions careers cybersecurity electronic instructions for use events investors inclusion and engagement literature news media and blogs our company ethics and compliance support training 2026 bd all rights reserved bd and the bd logo are trademarks of becton dickinson and company all other trademarks are the property of their respective owners contact us cookie preferences privacy notice terms of use website accessibility your privacy choices